Page last updated: 2024-11-03

probenecid and Erythema Multiforme

probenecid has been researched along with Erythema Multiforme in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.

Research Excerpts

ExcerptRelevanceReference
" burgdorferi to survive in the former erythema migrans sites of our antibiotic-treated patients, as well as their favorable clinical response, supports the use of doxycycline or combined amoxicillin and probenecid in the treatment of early Lyme disease but does not preclude the survival of the organism in other tissues."3.68Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease. ( Berger, BW; Coleman, L; Johnson, RC; Kodner, C, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, BW1
Johnson, RC1
Kodner, C1
Coleman, L1

Other Studies

1 other study available for probenecid and Erythema Multiforme

ArticleYear
Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease.
    Journal of the American Academy of Dermatology, 1992, Volume: 27, Issue:1

    Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Borrelia burgdorferi Group; Doxycycline; Erythema M

1992